MedPath

Matrix Metalloproteinases's in Oral Biofluids During Pregnancy and Postpartum

Completed
Conditions
Pregnancy
Interventions
Other: Saliva collection
Other: GCF collection
Registration Number
NCT03516565
Lead Sponsor
Aydin Adnan Menderes University
Brief Summary

The aim of this study was to investigate salivary and gingival crevicular fluid (GCF) levels of MMP-8, MMP-9 and TIMP-1 during 2/3 trimester of pregnancy and after delivery

Detailed Description

MMP-8 and MMP-9 have been reported to reflect the inflammatory status in periodontal tissues and, therefore represent as potential biomarkers of periodontitis. The balance between tissue inhibitors of metalloproteinases (TIMPs) and MMPs play an important role in maintaining the integrity of healthy periodontium.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
114
Inclusion Criteria
  • Pregnant group included women, who were in their second trimester (weeks 16-24) and third trimester (weeks 25-34)
Exclusion Criteria
  • (a) any known systemic disease, (b) periodontal treatment within the last six months, (c) patients having less than 10 teeth, (d) smokers and (e) individuals with BMI > 30 kg/m2

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-pregnant groupSaliva collectionWomen who were systemically healthy and non-pregnant.
Postpartum groupSaliva collectionPostpartum group included women, who were evaluated 6 months after giving birth
Pregnancy groupSaliva collectionPregnant group included women, who were in their second trimester (weeks 16-24) and third trimester (weeks 25-34)
Postpartum groupGCF collectionPostpartum group included women, who were evaluated 6 months after giving birth
Non-pregnant groupGCF collectionWomen who were systemically healthy and non-pregnant.
Pregnancy groupGCF collectionPregnant group included women, who were in their second trimester (weeks 16-24) and third trimester (weeks 25-34)
Primary Outcome Measures
NameTimeMethod
Changing MMP-9 levels6 months

Salivary and GCF level measured by ELISA

Changing TIMP-1 levels6 months

Salivary and GCF level measured by ELISA

Changing MMP-8 levels6 months

Salivary and GCF level measured by IFMA

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath